関連する実験動画

Updated: Sep 4, 2026

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

ヒトリンパ球の血清学的タイプ化は,ホモグラフ処理後に得られた免疫血清によるものです

R L WALFORD, R GALLAGHER, J R SJAARDA

    Science (New York, N.Y.)
    |May 15, 1964
    PubMed
    まとめ

    皮膚同移植からのヒト血清は,特定のリンパ球に対する細胞毒性活性を示した. このリンパ球の反応性は遺伝的に伝染しているようで,ヒトのヒト相容性抗原を潜在的に特定する可能性がある.

    キーワード:
    抗体対抗体の反応血液型は,血液型によって決まる.遺伝学,人間について免疫血清とはリンパ球細胞はリンパ球細胞である.皮膚移植についてです.移植免疫学 移植免疫学

    さらに関連する動画

    Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood13:14

    Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

    Published on: February 6, 2018

    Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells10:32

    Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells

    Published on: June 5, 2015

    関連する概念動画

    Hybridoma Technology01:31

    Hybridoma Technology

    Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
    Hybridoma Selection
    Commonly used fusion techniques — electroporation, polyethylene glycol...